GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (OTCPK:AWKNF) » Definitions » Operating Margin %

Awakn Life Sciences (Awakn Life Sciences) Operating Margin % : -2,342.86% (As of Oct. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Awakn Life Sciences's Operating Income for the three months ended in Oct. 2023 was $-0.49 Mil. Awakn Life Sciences's Revenue for the three months ended in Oct. 2023 was $0.02 Mil. Therefore, Awakn Life Sciences's Operating Margin % for the quarter that ended in Oct. 2023 was -2,342.86%.

The historical rank and industry rank for Awakn Life Sciences's Operating Margin % or its related term are showing as below:

AWKNF' s Operating Margin % Range Over the Past 10 Years
Min: -4150   Med: -2382.43   Max: -452.18
Current: -452.18


AWKNF's Operating Margin % is ranked worse than
62.96% of 1026 companies
in the Biotechnology industry
Industry Median: -175.525 vs AWKNF: -452.18

Awakn Life Sciences's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Awakn Life Sciences's Operating Income for the three months ended in Oct. 2023 was $-0.49 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Oct. 2023 was $-6.94 Mil.


Awakn Life Sciences Operating Margin % Historical Data

The historical data trend for Awakn Life Sciences's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences Operating Margin % Chart

Awakn Life Sciences Annual Data
Trend Jan21 Jan22 Jan23
Operating Margin %
- -4,149.20 -614.72

Awakn Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -349.55 -381.79 -5,826.32 -2,342.86

Competitive Comparison of Awakn Life Sciences's Operating Margin %

For the Biotechnology subindustry, Awakn Life Sciences's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Awakn Life Sciences's Operating Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Awakn Life Sciences's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Awakn Life Sciences's Operating Margin % falls into.



Awakn Life Sciences Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Awakn Life Sciences's Operating Margin % for the fiscal year that ended in Jan. 2023 is calculated as

Operating Margin %=Operating Income (A: Jan. 2023 ) / Revenue (A: Jan. 2023 )
=-6.848 / 1.114
=-614.72 %

Awakn Life Sciences's Operating Margin % for the quarter that ended in Oct. 2023 is calculated as

Operating Margin %=Operating Income (Q: Oct. 2023 ) / Revenue (Q: Oct. 2023 )
=-0.492 / 0.021
=-2,342.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Awakn Life Sciences  (OTCPK:AWKNF) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Awakn Life Sciences Operating Margin % Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Awakn Life Sciences (Awakn Life Sciences) Business Description

Traded in Other Exchanges
Address
301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2
Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting the people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences (Awakn Life Sciences) Headlines